HOTAIR is a promising novel biomarker in patients with thyroid cancer

Experimental and Therapeutic Medicine

Volumn 13, Issue 5, 2017, Pages 2274-2278

  Zhang, Yifei ^a   Yu, Sui ^a   Jiang, Lixin ^a   Wang, Xixun ^a   Song, Xiaojing ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Biomarker; HOX transcript antisense RNA; Long non coding RNAs; Thyroid cancer

Indexed keywords

BIOLOGICAL MARKER; HOX TRANSCRIPT ANTISENSE RNA; LONG UNTRANSLATED RNA; RNA 18S; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER PROGNOSIS; CARCINOGENESIS; CELL CULTURE; CELL INVASION ASSAY; CELL PROLIFERATION ASSAY; CHROMATIN; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CANCER; TUMOR INVASION;

EID: 85032568019     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2017.4231     Document Type: Article

References (24)

1. Fofi C, Festuccia F, Barberi S, Apponi F, Chiacchiararelli L, Scopinaro F, Punzo G and Menè P: Hemodialysis in patients requiring 131I treatment for thyroid carcinoma. Int J Artif Organs 36: 439-443, 2013.
2. Sherman EJ, Su YB, Lyall A, Schöder H, Fury MG, Ghossein RA, Haque S, Lisa D, Shaha AR, Tuttle RM and Pfister DG: Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma. Thyroid 23: 593-599, 2013.
3. Wakabayashi H, Taki J, Inaki A, Toratani A, Kayano D and Kinuya S: Extremity Radioactive Iodine Uptake on Post-therapeutic Whole Body Scan in Patients with Differentiated Thyroid Cancer. Asia Ocean J Nucl Med Biol 3: 26-34, 2015.
4. Netea-Maier RT, Klück V, Plantinga TS and Smit JW: Autophagy in thyroid cancer: Present knowledge and future perspectives. Front Endocrinol (Lausanne) 6: 22, 2015.
5. Mattick JS: RNA regulation: A new genetics? Nat Rev Genet 5: 316-323, 2004.
6. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464: 1071-1076, 2010.
7. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van Oudenaarden A, et al: Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 106: 11667-11672, 2009.
8. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as modular scaffold of histone modification complexes. Science 329: 689-693, 2010.
9. Huang L, Liao LM, Liu AW, Wu JB, Cheng XL, Lin JX and Zheng M: Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer. Arch Gynecol Obstet 290: 717-723, 2014.
10. Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, et al: Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 71: 6320-6326, 2011.
11. Zhang JX, Han L, Bao ZS, Wang YY, Chen LY, Yan W, Yu SZ, Pu PY, Liu N, You YP, et al: HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro Oncol 15: 1595-1603, 2013.
12. Thum T and Condorelli G: Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circ Res 116: 751-762, 2015.
13. Ling H: Non-coding RNAs: Therapeutic Strategies and Delivery Systems. Adv Exp Med Biol 937: 229-237, 2016.
14. Latronico MV and Condorelli G: Therapeutic applications of noncoding RNAs. Curr Opin Cardiol 30: 213-221, 2015.
15. He D, Wang J, Zhang C, Shan B, Deng X, Li B, Zhou Y, Chen W, Hong J, Gao Y, et al: Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer. Mol Cancer 14: 73, 2015.
16. Hu Y, Xu K and Yagüe E: MiR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer. Breast Cancer Res Treat 151: 269-280, 2015.
17. Rebucci M, Sermeus A, Leonard E, Delaive E, Dieu M, Fransolet M, Arnould T and Michiels C: MiRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1. Mol Cancer 14: 79, 2015.
18. Jin X, Sun Y, Yang H, Li J, Yu S, Chang X, Lu Z and Chen J: Deregulation of the MiR-193b-KRAS axis contributes to impaired cell growth in pancreatic cancer. PloS One 10: e0125515, 2015.
19. Kohls K, Schmidt D, Holdenrieder S, Müller SC and Ellinger J: Detection of cell-free lncRNA in serum of cancer patients. Urologe A 54: 819-825, 2015 (In German).
20. Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H, Wang Y, Zeng J, Song Y, Gao W, et al: The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. J Transl Med 13: 84, 2015.
21. Yang Q, Xu E, Dai J, Liu B, Han Z, Wu J, Zhang S, Peng B, Zhang Y and Jiang Y: A novel long noncoding RNA AK001796 acts as an oncogene and is involved in cell growth inhibition by resveratrol in lung cancer. Toxicol Appl Pharmacol 285: 79-88, 2015.
22. Deng L, Yang SB, Xu FF and Zhang JH: Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge. J Exp Clin Cancer Res 34: 18, 2015.
23. Ishibashi M, Kogo R, Shibata K, Sawada G, Takahashi Y, Kurashige J, Akiyoshi S, Sasaki S, Iwaya T, Sudo T, et al: Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncol Rep 29: 946-950, 2013.
24. Yu X and Li Z: Long non-coding RNA HOTAIR: A novel oncogene (Review). Mol Med Rep 12: 5611-5618, 2015.